Context: Cell division cycle 73 (CDC73), encoding the protein parafibromin, is the most prevalent mutated gene in familial and sporadic parathyroid carcinoma (PC).Objective: To identify additional genetic abnormalities in PCs.Design: Whole-exome sequencing was performed using DNA from seven pairs of matched PCs and one triplet containing double primary tumor and normal leukocyte. Somatic variants were confirmed using Sanger sequencing and recurrently mutated genes were assessed in 13 additional PCs as well as 40 parathyroid adenomas (PA).Results: PC had an average of 51 somatic variants/tumor (range 3-176) with approximately 58% of variants occurring as nonsynonymous single nucleotide variants. The importance of CDC73 in PC is reinforced wi...
The molecular basis of both benign and malignant parathyroid neoplasia is still poorly understood. W...
BackgroundParathyroid carcinoma (PC) is a rare endocrine malignancy that can cause life-threatening ...
The molecular basis of both benign and malignant parathyroid neoplasia is still poorly understood. W...
Context: Cell division cycle 73 (CDC73), encoding the protein parafibromin, is the most prevalent mu...
Parathyroid carcinoma (PC) is an extremely rare malignancy lacking effective therapeutic interventio...
Context: Genetic abnormalities, such as those of multiple endocrine neoplasia type 1 (MEN1) and Cycl...
CONTEXT: Genetic abnormalities, such as those of multiple endocrine neoplasia type 1 (MEN1) and Cycl...
Parathyroid carcinoma is a rare endocrine malignancy with an estimated incidence of less than 1 per ...
Parathyroid carcinoma (PC) may occur as part of a complex hereditary syndrome or an isolated (i.e. n...
Parathyroid carcinoma (PC) is a rare neoplasia difficult to diagnose preoperatively. It mainly occur...
Mutations in the hyperparathyroidism type 2 (HRPT2/CDC73) gene and alterations in the parafibromin p...
Mutations in the hyperparathyroidism type 2 (HRPT2/CDC73) gene and alterations in the parafibromin p...
Parathyroid disease and tumor formation can occur both as a primary process and as a complication of...
The molecular basis of both benign and malignant parathyroid neoplasia is still poorly understood. W...
BackgroundParathyroid carcinoma (PC) is a rare endocrine malignancy that can cause life-threatening ...
The molecular basis of both benign and malignant parathyroid neoplasia is still poorly understood. W...
Context: Cell division cycle 73 (CDC73), encoding the protein parafibromin, is the most prevalent mu...
Parathyroid carcinoma (PC) is an extremely rare malignancy lacking effective therapeutic interventio...
Context: Genetic abnormalities, such as those of multiple endocrine neoplasia type 1 (MEN1) and Cycl...
CONTEXT: Genetic abnormalities, such as those of multiple endocrine neoplasia type 1 (MEN1) and Cycl...
Parathyroid carcinoma is a rare endocrine malignancy with an estimated incidence of less than 1 per ...
Parathyroid carcinoma (PC) may occur as part of a complex hereditary syndrome or an isolated (i.e. n...
Parathyroid carcinoma (PC) is a rare neoplasia difficult to diagnose preoperatively. It mainly occur...
Mutations in the hyperparathyroidism type 2 (HRPT2/CDC73) gene and alterations in the parafibromin p...
Mutations in the hyperparathyroidism type 2 (HRPT2/CDC73) gene and alterations in the parafibromin p...
Parathyroid disease and tumor formation can occur both as a primary process and as a complication of...
The molecular basis of both benign and malignant parathyroid neoplasia is still poorly understood. W...
BackgroundParathyroid carcinoma (PC) is a rare endocrine malignancy that can cause life-threatening ...
The molecular basis of both benign and malignant parathyroid neoplasia is still poorly understood. W...